Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or ...

The study will test the combination, which aims to boost CD19 expression to make CAR T-cell therapy more effective, in patients with solid tumors.

Second, for our mRNA cancer immunotherapies, we have recently provided 2 Phase II updates that support and inform our current ...

Different subsets of γδ T cells display differential expression of immune checkpoint receptors (ICRs) and have distinct ...

Findings showed both zanidatamab treatment arms demonstrated statistically significant and clinically meaningful improvements in PFS vs the SOC arm.

The Poco F8 Ultra has a 6.9-inch OLED display, which Poco calls HyperRGB - their 'full RGB subpixel structure' does appear to ...

My 39-year-old brother was just diagnosed with gastric cancer. The diagnosis was especially shocking because of his age. Is ...

The FDA has granted fast track designation (FTD) to AVZO-103, a potential best-in-class Nectin4/TROP2 bispecific antibody-drug conjugate (ADC) for the treatment of patients with locally advanced or ...

"Kelun-Biotech’s ADC plus Keytruda touts first-line success in late-stage NSCLC" was originally created and published by ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

The Realme GT 8 Pro is equipped with one of highest-specced displays in the lineup, and in the sister brands' lineups too.

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...